Austin, D., Pell, J. and Oldroyd, K.G. (2008) Drug-eluting stents: do the risks really outweigh the benefits? Heart, 94(2), pp. 127-128. (doi: 10.1136/hrt.2007.123141)
Full text not currently available from Enlighten.
Abstract
The safety of drug-eluting stents (DES) has been called into question by studies suggesting a predisposition to late stent thrombosis—an uncommon but potentially fatal complication.1–4 Consequently, balancing the risks and benefits of DES use in an individual patient undergoing percutaneous coronary intervention (PCI) is challenging, particularly as studies have often been unrepresentative of routine practice, underpowered, prone to bias or used inconsistent definitions of stent thrombosis.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Pell, Professor Jill |
| Authors: | Austin, D., Pell, J., and Oldroyd, K.G. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences |
| Journal Name: | Heart |
| Publisher: | BMJ Publishing Group |
| ISSN: | 1355-6037 |
| ISSN (Online): | 1468-201X |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric